The labels carry several warnings of the risk of [[injection site reaction]]s, [[hypersensitivity]] reactions; [[kidney damage|kidney]], [[Liver damage|liver]], and [[pancreatitis|pancreas]] damage; trouble with vision; and adverse affects in skin including damage due to [[phototoxicity]], [[squamous cell skin cancer]], and [[Stevens-Johnson syndrome]]; in long-term use there is a warning of the risk of [[Skeletal fluorosis|bone fluorosis]] and [[periostitis]].<ref name=USlabel2017/><ref name=UKlabel2017/>

 


 
Additionally, very common adverse affects, occurring in more than 10% of people, include peripheral edema, headaches, trouble breathing, diarrhea, vomiting, abdominal pain, nausea, rashes, and fever.<ref name=UKlabel2017/>

 


 
Common adverse affects, occurring in between 1 and 10% of people, include sinus infections, low numbers of white and red blood cells ([[agranulocytosis]], [[pancytopenia]], [[thrombocytopenia]], [[leukopenia]], and [[anemia]]), low blood sugar, reduced amount of potassium and sodium, depression, hallucinations, anxiety, insomnia, agitation, confusion, convulsions, fainting, tremor, weakness, tingling, sleepiness, dizziness, bleeding retina, irregular heart beats, slow or fast heart beats, low blood pressure, inflamed veins, acute respiratory distress syndrome, pulmonary edema, inflamed lips, swollen face, stomach upset, constipation, gingivitis, jaundice, hair loss, flaky skin, itchiness, red skin, back pain, chest pain, and chills.<ref name=UKlabel2017/>

 

